Initial presentation of an unspecified peripheral T-cell lymphoma as inflammatory polyarthritis and hypereosinophilia
Keywords:
rheumatoid arthritis (RA), peripheral T-cell lymphoma-unspecified (PTCL-U), Hypereosinophilia, arthritis, lymphomaAbstract
Premise: There may be signs of joint and bone involvement in hematologic malignancies, but it is most rare for hematologic malignancies like lymphomas to present with joint symptoms. Patient: A 49-year-old male patient was admitted with rheumatoid arthritis-like symmetrical polyarthritis, morning stiffness, cutaneous vasculitis and hypereosinophilia. Autoantibodies, like rheumatoid factor, anti-citrullinated cyclic peptide, antinuclear antibody, anti-nuclear cytoplasmic antibody, were negative. After 4 months of follow-up, the patient developed a diffuse cutaneous rash and multiple lymphadenopathies. Lymph node biopsy was compatible with peripheral T-cell lymphoma, unspecified. Result: The patient was administered, respectively, CHOP and ICE chemotherapy regimens to which he was refractory. He died from infection and respiratory failure. Conclusion: It should be borne in mind that T-cell lymphomas may have unusual presentations with arthritis and hypereosinophilia.
Downloads
Published
Issue
Section
License
OPEN ACCESS
All the articles of the European Journal of Oncology and Environmental Health are published with open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0 http://creativecommons.org/licenses/by/4.0/). This means that the author(s) retain copyright, but the content is free to download, distribute and adapt for commercial or non-commercial purposes, given appropriate attribution to the original article.
The articles in the previous edition of the Journal (European Journal of Oncology) are made available online with open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0 http://creativecommons.org/licenses/by/4.0/).
Upon submission, author(s) grant the Journal the license to publish their original unpublished work within one year, and the non exclusive right to display, store, copy and reuse the content. The CC-BY Creative Commons attribution license enables anyone to use the publication freely, given appropriate attribution to the author(s) and citing the Journal as the original publisher. The CC-BY Creative Commons attribution license does not apply to third-party materials that display a copyright notice to prohibit copying. Unless the third-party content is also subject to a CC-BY Creative Commons attribution license, or an equally permissive license, the author(s) must comply with any third-party copyright notices.